Demystifying the role of tumor HPV status in recurrent and/or metastatic squamous cell carcinoma of the head and neck

被引:7
|
作者
Spreafico, A. [1 ]
Amir, E. [1 ]
Siu, L. L. [1 ]
机构
[1] Univ Toronto, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
关键词
OROPHARYNGEAL CANCER; HUMAN-PAPILLOMAVIRUS; FLUOROURACIL; CHEMOTHERAPY; CISPLATIN; CETUXIMAB; SURVIVAL; IMPACT;
D O I
10.1093/annonc/mdu095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:760 / 762
页数:3
相关论文
共 50 条
  • [31] Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Sacco, Assuntina G.
    Cohen, Ezra E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29) : 3305 - +
  • [32] Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck
    Machiels, Jean-Pascal
    Schmitz, Sandra
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (03) : 359 - 371
  • [33] Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Thurnher, D
    Kornfehl, J
    Burian, M
    Gedlicka, C
    Selzer, E
    Quint, C
    Neuchrist, C
    Kornek, GV
    [J]. ANTI-CANCER DRUGS, 2001, 12 (03) : 205 - 208
  • [34] Prognostic value of hyponatremia on metastatic or recurrent head and neck squamous cell carcinoma
    Melo Alvim Moreira, C.
    Semedo, P.
    Paiva, R.
    Lobo Martins, S.
    Pais, H.
    Costa, A. L.
    Ribeiro, L.
    Costa, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 37 - 37
  • [35] ALTERNATING REGIMENS IN RECURRENT AND METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    COGNETTI, F
    MOLINARI, A
    CARLINI, P
    FRASSINETI, GL
    PINNARO, P
    MARANGOLO, M
    [J]. ONCOLOGY, 1987, 44 (05) : 270 - 272
  • [36] Weekly Docetaxel in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Specenier, Pol
    Rasschaert, Marika
    Vroman, Philippe
    Van den Brande, Jan
    Dyck, Joke
    Schrijvers, Dirk
    Huizing, Manon T.
    Vermorken, Jan B.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 472 - 477
  • [37] Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Borel, Christian
    Jung, Alain C.
    Burgy, Mickael
    [J]. CANCERS, 2020, 12 (09) : 1 - 19
  • [38] Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Colevas, A. Dimitrios
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (17) : 2644 - 2652
  • [39] Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma
    Adamo, V
    Ferraro, G
    Pergolizzi, S
    Sergi, C
    Laudani, A
    Settineri, N
    Alafaci, E
    Scimone, A
    Spano, F
    Spitaleri, G
    [J]. ORAL ONCOLOGY, 2004, 40 (05) : 525 - 531
  • [40] Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Hitt, R
    Amador, ML
    Quintela-Fandino, M
    Jimeno, A
    del Val, O
    Hernando, S
    Cortes-Funes, H
    [J]. CANCER, 2006, 106 (01) : 106 - 111